Software Alternatives, Accelerators & Startups

Close VS TinyNPS

Compare Close VS TinyNPS and see what are their differences

Close logo Close

A CRM with built-in calling, SMS, and email

TinyNPS logo TinyNPS

Simple NPS feedback
  • Close Landing page
    Landing page //
    2023-09-15
Not present

Close videos

Close Netflix Review

More videos:

  • Review - CLOSE (2019) - Netflix Original Movie - One Minute Movie Review
  • Review - Close: Netflix: Ending Explained + Real Life Story Of The Female Bodyguard To The Rich And Famous

TinyNPS videos

No TinyNPS videos yet. You could help us improve this page by suggesting one.

+ Add video

Category Popularity

0-100% (relative to Close and TinyNPS)
CRM
93 93%
7% 7
User Experience
0 0%
100% 100
Sales
100 100%
0% 0
Productivity
100 100%
0% 0

User comments

Share your experience with using Close and TinyNPS. For example, how are they different and which one is better?
Log in or Post with

Social recommendations and mentions

Based on our record, Close seems to be more popular. It has been mentiond 8 times since March 2021. We are tracking product recommendations and mentions on various public social media platforms and blogs. They can help you identify which product is more popular and what people think of it.

Close mentions (8)

  • Ask HN: Who is hiring? (March 2024)
    Close (https://close.com) | Multiple Product & Engineering Roles | REMOTE (US) Close is a bootstrapped, profitable, completely remote, ~90 person team of thoughtful individuals who value autonomy and impact. Since 2013, we’ve been building a CRM for small businesses with a focus on better communication, without the hassle of manual data entry or complex UI. We're looking for experienced people in the following... - Source: Hacker News / 3 months ago
  • Ask HN: Who is hiring? (February 2024)
    Close (https://close.com) | Multiple Product & Engineering Roles | REMOTE (US) Close is a bootstrapped, profitable, completely remote, ~90 person team of thoughtful individuals who value autonomy and impact. Since 2013, we’ve been building a CRM for small businesses with a focus on better communication, without the hassle of manual data entry or complex UI. We're looking for experienced people in the following... - Source: Hacker News / 4 months ago
  • Why this simple email template can help with your sign-ups conversion
    This sign-up sales email from Close.io (now close.com) will likely increase your conversion rate. Here's why it works well:. Source: about 1 year ago
  • managing SAAS pipeline
    Do you need something to manage outbound email sequences? close.com or quickmail.io are both pretty cool. Source: almost 2 years ago
  • A modern data stack for startups
    On the left, you'll see data sources (only a sample, we have many more than this), tools where we generate and work with data. One of them is Product, the Postgres database that powers incident.io, while Intercom and Close are SaaS we use to run our business. - Source: dev.to / about 2 years ago
View more

TinyNPS mentions (0)

We have not tracked any mentions of TinyNPS yet. Tracking of TinyNPS recommendations started around Mar 2021.

What are some alternatives?

When comparing Close and TinyNPS, you can also consider the following products

Pipedrive - Sales pipeline software that gets you organized. Helps you focus on the right deals, so easy to use that salespeople just love it. Great for small teams.

Interactive NPS Calculator (by Delighted) - Calculate your NPS easily with this interactive free tool.

Zoho CRM - Omnichannel CRM for Businesses of all sizes

Vitally - Analytics and insights to drive B2B startup success 🚀

Insightly - Insightly is the easy, powerful and affordable online Customer Relationship & Project Management Software used by over 400,000 small businesses world wide

Salesmachine - Salesmachine scores your customer health in real-time and informs your team who need attention to prevent churn and improve expansion. Thanks to the Product Qualified Leads scoring method and tasks & playbooks automation, convert min. +25% trials.